Takeda Pharmaceutical (TAK) Asset Utilization Ratio (2019 - 2026)

Takeda Pharmaceutical's Asset Utilization Ratio history runs 8 years deep, the most recent figure standing at 0.46 for Q1 2026.

• On a quarterly basis, Asset Utilization Ratio fell 3.35% year-over-year to 0.46 in Q1 2026; TTM through Mar 2026 was 0.46, a 3.35% decrease from a year earlier, with the FY2026 full-year figure at 0.3, changed 0.39% from the prior year.
• Asset Utilization Ratio eased to 0.46 in Q1 2026 per TAK's latest filing, from 0.47 in the prior quarter.
• Across five years, Asset Utilization Ratio topped out at 0.49 in Q2 2025 and bottomed at 0.28 in Q2 2022.
• The 5-year median for Asset Utilization Ratio is 0.45 (2023), against an average of 0.4.
• Across the five-year window, Asset Utilization Ratio soared 52.42% in 2024 and fell 3.35% in 2026, its largest moves.
• Year by year, Asset Utilization Ratio stood at 0.31 in 2022, then jumped by 47.35% to 0.45 in 2023, then climbed by 4.24% to 0.47 in 2024, then gained by 0.66% to 0.47 in 2025, then fell by 2.34% to 0.46 in 2026.
• Per Business Quant, the three latest TAK Asset Utilization Ratio figures stand at 0.46 (Q1 2026), 0.47 (Q4 2025), and 0.48 (Q3 2025).